Hjem
Reidun Æsøys bilde

Reidun Æsøy

Forsker
  • E-postreidun.asoy@uib.no
  • Besøksadresse
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • Vis forfatter(e) (2024). Synthesis, kinase inhibition and anti-leukemic activities of diversely substituted indolopyrazolocarbazoles. European Journal of Medicinal Chemistry.
  • Vis forfatter(e) (2022). Synthesis of new pyrazolo[4,3-a]phenanthridine Pim-1 inhibitors and evaluation of their cytotoxic activity towards the MOLM-13 acute myeloid leukemia cell line. Bioorganic & Medicinal Chemistry Letters. 5 sider.
  • Vis forfatter(e) (2022). A novel bicyclic lactone and other polyphenols from the commercially important vegetable Anthriscus cerefolium. Scientific Reports.
  • Vis forfatter(e) (2021). New prodrugs and analogs of the phenazine 5,10-dioxide natural products iodinin and myxin promote selective cytotoxicity towards human acute myeloid leukemia cells. RSC Medicinal Chemistry. 767-778.
  • Vis forfatter(e) (2021). Bioactive peptides from microalgae: Focus on anti-cancer and immunomodulating activity. Physiologia Plantarum : An International Journal for Plant Biology. 612-623.
  • Vis forfatter(e) (2020). New CDK8 inhibitors as potential anti-leukemic agents – Design, synthesis and biological evaluation. Bioorganic & Medicinal Chemistry. 1-8.
  • Vis forfatter(e) (2019). Mice depleted for Exchange Proteins Directly Activated by cAMP (Epac) exhibit irregular liver regeneration in response to partial hepatectomy. Scientific Reports. 1-17.
  • Vis forfatter(e) (2019). A kinase inhibitor with anti-Pim kinase activity is a potent and selective cytotoxic agent toward acute myeloid leukemia. Molecular Cancer Therapeutics. 567-578.
  • Vis forfatter(e) (2018). Deletion of exchange proteins directly activated by cAMP (Epac) causes defects in hippocampal signaling in female mice. PLOS ONE.
  • Vis forfatter(e) (2017). Total synthesis and antileukemic evaluations of the phenazine 5,10-dioxide natural products iodinin, myxin and their derivatives. Bioorganic & Medicinal Chemistry. 2285-2293.
  • Vis forfatter(e) (2016). Role of EPAC in cAMP-mediated actions in adrenocortical cells. Frontiers in Endocrinology. 7 sider.
  • Vis forfatter(e) (2016). Long-term consumption of an obesogenic high fat diet prior to ischemia-reperfusion mediates cardioprotection via Epac1-dependent signaling. Nutrition & Metabolism. 1-11.
  • Vis forfatter(e) (2014). Regulation of CDKN2B expression by interaction of Arnt with Miz-1 - a basis for functional integration between the HIF and Myc gene regulatory pathways. Molecular Cancer.
  • Vis forfatter(e) (2010). The alkylating prodrug J1 can be activated by aminopeptidase N, leading to a possible target directed release of melphalan. Biochemical Pharmacology.
  • Vis forfatter(e) (2008). Deoxyribonucleic acid methylation controls cell type-specific expression of steroidogenic factor 1. Endocrinology. 5599-5609.
  • Vis forfatter(e) (2008). An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells. Molecular Cancer Research.
  • Vis forfatter(e) (2002). Activation of cAMP-dependent protein kinase increases the protein level of steroidogenic factor-1. Endocrinology.
  • Vis forfatter(e) (1998). Biochemical and functional analysis of nuclear receptors as targets in cAMP-dependent control of bovine CYP17. Endocrine Research.
Doktorgradsavhandling
  • Vis forfatter(e) (2004). Modifications of transcriptional regulation by protein-protein interactions and signal transduction.
Poster
  • Vis forfatter(e) (2022). Precision medicine in childhood cancer - a representative case of neuroblastoma.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) (2021). Chemical diversity and cellular effects of antifungal cyclic lipopeptides from cyanobacteria . Physiologia Plantarum : An International Journal for Plant Biology. 639-650.
  • Vis forfatter(e) (2015). Insights into Orphan Nuclear Receptors as Prognostic Markers and Novel Therapeutic Targets for Breast Cancer. Frontiers in Endocrinology.
  • Vis forfatter(e) (2002). Differential regulation of SF-1-cofactor interactions. Endocrine Research.

Se fullstendig oversikt over publikasjoner i CRIStin.